{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:11:17Z","timestamp":1787728277835,"version":"build-2784847793"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235640","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:51:16Z","timestamp":1596142276000},"page":"e0235640","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3246-2993","authenticated-orcid":true,"given":"Byoung-Geun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-4190","authenticated-orcid":true,"given":"Jun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ryung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-0127","authenticated-orcid":true,"given":"Jong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"pone.0235640.ref001","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00125-005-1896-y","article-title":"The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus","volume":"48","author":"A Dawson","year":"2005","journal-title":"Diabetologia"},{"key":"pone.0235640.ref002","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control","volume":"9","author":"G Borghetti","year":"2018","journal-title":"Front Physiol"},{"key":"pone.0235640.ref003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/diagnostics9030121","article-title":"Left ventricular diastolic dysfunction in type 2 diabetes-progress and perspectives","volume":"9","author":"ED Grigorescu","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"pone.0235640.ref004","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"H Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"pone.0235640.ref005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3904\/kjim.2016.208","article-title":"Diabetic cardiomyopathy: where we are and where we are going","volume":"32","author":"WS Lee","year":"2017","journal-title":"Korean J Intern Med"},{"key":"pone.0235640.ref006","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"WH Dillmann","year":"2019","journal-title":"Circ Res"},{"key":"pone.0235640.ref007","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"GH Jia","year":"2018","journal-title":"Circ Res"},{"key":"pone.0235640.ref008","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4239\/wjd.v10.i10.490","article-title":"Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date","volume":"10","author":"L Athithtan","year":"2019","journal-title":"World J Diabetes"},{"key":"pone.0235640.ref009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"SM Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"pone.0235640.ref010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00592-018-1253-5","article-title":"Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis","volume":"56","author":"LM Vetrone","year":"2019","journal-title":"Acta Diabetol"},{"key":"pone.0235640.ref011","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1681\/ASN.2016121341","article-title":"Chronic fluid overload and mortality in ESRD","volume":"28","author":"C Zoccali","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"pone.0235640.ref012","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.mayocp.2015.05.002","article-title":"Volume overload in heart failure: an evidence-based review of strategies for treatment and prevention","volume":"90","author":"BA Houston","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"pone.0235640.ref013","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"C Tuegel","year":"2017","journal-title":"Heart"},{"key":"pone.0235640.ref014","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"SF Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"pone.0235640.ref015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"RM Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"pone.0235640.ref016","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"WJ Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"pone.0235640.ref017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/ajcn\/85.1.80","article-title":"A whole-body model to distinguish excess fluid from the hydration of major body tissues","volume":"85","author":"PW Chamney","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"pone.0235640.ref018","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000167013","article-title":"Importance of whole-body bioimpedance spectroscopy for the management of fluid balance","volume":"27","author":"P Wabel","year":"2009","journal-title":"Blood Purif"},{"key":"pone.0235640.ref019","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"S Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"pone.0235640.ref020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"G Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"pone.0235640.ref021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"A Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0235640.ref022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9149(00)01366-7","article-title":"Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus","volume":"87","author":"M Zabalgoitia","year":"2001","journal-title":"Am J Cardiol"},{"key":"pone.0235640.ref023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"JK Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"pone.0235640.ref024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12933-014-0168-x","article-title":"Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes","volume":"14","author":"R Fontes-Carvalho","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0235640.ref025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2369-14-280","article-title":"Diastolic function is a strong predictor of mortality in patients with chronic kidney disease.","volume":"14","author":"A Farshid","year":"2013","journal-title":"BMC Nephrol"},{"key":"pone.0235640.ref026","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jjcc.2009.05.002","article-title":"Left ventricular diastolic dysfunction in the early stage of chronic kidney disease","volume":"54","author":"T Otsuka","year":"2009","journal-title":"J Cardiol"},{"key":"pone.0235640.ref027","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000486938","article-title":"Clinical impact of left ventricular diastolic dysfunction in chronic kidney disease","volume":"195","author":"T Ogawa","year":"2018","journal-title":"Contrib Nephrol"},{"key":"pone.0235640.ref028","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/HJH.0b013e3283220ecd","article-title":"Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease","volume":"27","author":"E Nardi","year":"2009","journal-title":"J Hypertens"},{"key":"pone.0235640.ref029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","article-title":"Clinical impact of left ventricular hypertrophy and implications for regression","volume":"52","author":"SM Artham","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"pone.0235640.ref030","doi-asserted-by":"crossref","first-page":"e010278","DOI":"10.1161\/JAHA.118.010278","article-title":"Extracellular fluid volume is an independent determinant of uncontrolled and resistant hypertension in chronic kidney disease: A nephrotest cohort study","volume":"7","author":"E Vidal-Petiot","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"pone.0235640.ref031","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"K Kalantar-Zadeh","year":"2009","journal-title":"Circulation"},{"key":"pone.0235640.ref032","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/cpf.12154","article-title":"Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects","volume":"35","author":"AM Asp","year":"2015","journal-title":"Clin Physiol Funct Imaging"},{"key":"pone.0235640.ref033","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabres.2011.12.021","article-title":"Association of left ventricular diastolic dysfunction with elevated NT-proBNP in type 2 diabetes mellitus patients with preserved ejection fraction: the supplemantary role of tissue doppler imaging parameters and NT-proBNP levels","volume":"96","author":"S Ciftel","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0235640.ref034","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.amjcard.2012.10.019","article-title":"Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC])","volume":"111","author":"RK Mishra","year":"2013","journal-title":"Am J Cardiol"},{"key":"pone.0235640.ref035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"SC Hung","year":"2014","journal-title":"Kidney Int"},{"key":"pone.0235640.ref036","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2840-9-89","article-title":"Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides","volume":"9","author":"S Romano","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0235640.ref037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors","volume":"17","author":"S Lahnwong","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"pone.0235640.ref038","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/ijerph16162965","article-title":"SGLT2 inhibitors: A review of their antidiabetic and cardioprotective effects","volume":"16","author":"A Tentolouris","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0235640.ref039","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00125-016-3956-x","article-title":"SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?","volume":"59","author":"N Sattar","year":"2016","journal-title":"Diabetologia"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:51:33Z","timestamp":1596142293000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235640"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Lionetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235640","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}